Ibrutinib plus venetoclax in relapsed/refractory CLL: results of the Bloodwise TAP Clarity study
Munir, T Rawstron, A Brock, K Vicente, S Yates, F Bishop, R Macdonald, D Fegan, C McCaig, A Schuh, A
Munir, T
Rawstron, A
Brock, K
Vicente, S
Yates, F
Bishop, R
Macdonald, D
Fegan, C
McCaig, A
Schuh, A
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Munir T, Rawstron A, Brock K, Vicente S, Yates F, Bishop R, et al. Ibrutinib plus venetoclax in relapsed/refractory CLL: results of the Bloodwise TAP Clarity study. Br J Haemat. 2019; 185:25.